Sr. Applied Research Engineer - OCE - Burlington MA

Job Description: We are seeking a highly motivated and experienced scientist or engineer to join our Applied Research team and contribute to the advancement of next-generation technologies within our Corneal Health (CH) product portfolio. This role will play a central part in driving early-stage innovation, technology development, and translational research efforts aimed at expanding the capabilities and clinical impact of our ophthalmic medical device platforms. The successful candidate will work at the intersection of experimental science, engineering, and clinical translation to develop new technologies and methodologies. A key focus of this role will be designing, implementing, and translating imaging, and computational approaches that enable improved understanding and quantification of corneal structure and biomechanics. The ideal candidate will bring deep expertise spanning experimental system development, signal processing and algorithm design, and biomechanical modeling, with a strong interest in translating research concepts into robust, validated technologies. Generous. Innovative. Leadership-driven. Family-oriented. Socially responsible. Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases. Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients. Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra “We’ll Go First,” which articulates our willingness to take chances, our determination to forge new ground, and our commitment to continuous improvement in all that we do. Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts. Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law. All offers of employment are contingent upon the successful completion of a background check, including successfully passing a drug screen, based on the position and local regulations.